✦ LIBER ✦

A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3receptor antagonist: correlation with anti-emetic response

✍ Scribed by J. Carmichael; B. M. J. Cantwell; C. M. Edwards; B. D. Zussman; S. Thompson; W. G. Rapeport; A. L. Harris

Book ID: 104684445
Publisher: Springer
Year: 1989
Tongue: English
Weight: 479 KB
Volume: 24
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00254104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and anti-emetic efficac

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist

✍ Cassidy, J; Raina, V; Lewis, C; Adams, L; Soukop, M; Rapeport, WG; Zussman, BD; 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 608 KB

A phase I study of a new 5HT3-receptor a

A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting

✍ Geoffrey Falkson; Adriaan J. Zyl 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 370 KB

In a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 micrograms/kg was given to 24 patients. All patients received cytostatic treatment expected to cause nausea and vomiting. During the first 24 h, 12 patients were completely protected from nausea and vomiting, 4 experien

Neural and psychological predictors of t

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study

✍ J. M. JARCHO; L. CHANG; S. M. BERMAN; B. SUYENOBU; B. D. NALIBOFF; M. D. LIEBERM 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB